'Don't freak out': Ugur Sahin takes a different tone on Omicron than his mRNA counterpart — reports
Whereas some public health officials and biopharma leaders — including Moderna CEO Stéphane Bancel — are sounding the alarm over the new Omicron coronavirus variant, BioNTech chief Ugur Sahin is pressing a more cautious approach.
In interviews Tuesday with the Wall Street Journal and Reuters, Sahin cautioned that little is yet known of the variant’s ability to cause severe Covid-19, and T cell responses among the vaccinated would likely remain strong. Though the biotech is still conducting lab tests to determine whether antibody protection will be diminished, Sahin isn’t pressing the panic button.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
